The life sciences industry is – as its name suggests – a lively sector, characterized by dynamic change, vitality and long-term growth. Our globalizing economy and the rapidly evolving needs of its diverse markets present virtually limitless opportunities. As the industry continues to evolve, Grant Thornton is conducting a series of interviews delving into key issues and challenges for this emerging space. Each interview explores the experience of a life sciences executive.
Patient first: A discussion with life sciences executive Bob Baltera
A culture of innovation: A Q&A with Jeffrey S. Hatfield, CEO of Vitae Pharmaceuticals